An Overview of β-Oxidation Disorders

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2009, Vol 63, Issue

Abstract

Fatty acids (FAs) are components of cell membrane, enzymes, and hormones and are one of the most important energy sources for many organisms. There are several types of fatty-acid oxidative degradation processes in the cell, namely alpha-, beta-, and omega-oxidation, which take place in specialized cellular structures: mitochondria and peroxisomes. The best-known pathway is β-oxidation taking place in the matrix of mitochondria. It is responsible for the degradation of straight-chain FAs. The pathway of β-oxidation of fatty acids is comprised of at least 25 enzymes and specific transport proteins. Deficiencies in 18 of them have been demonstrated to cause disease in humans. These diseases show a wide variety of symptoms, which can be expressed at random, one at a time, or in sets, characteristic of the individual rather than the metabolic character of the disease. Disorders of β-oxidation are believed to cause about 1–3% of unexplained sudden infant deaths (SIDS). Acute fatty liver of pregnancy (AFLP) and the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome), which have significant neonatal and maternal morbidity and mortality, have also been associated with β-oxidation deficiency in fetuses. This review summarizes recent observations on disorders associated with fatty-acid oxidation: deficiencies of β-oxidation enzymes, namely VLCAD, TFP and LCHAD, MCAD, MCKAT, M/SCHAD, and SCAD, and deficiencies of the enzymes TCP I, CT, and CPT II of the carnitine cycle.

Authors and Affiliations

Dariusz Moczulski, Iwona Majak

Keywords

Related Articles

Endoglina jako cel terapii przeciwnowotworowej*

Naczynia krwionośne mają istotny wpływ na wzrost nowotworów. Zahamowanie proliferacji komórek śródbłonkowych naczyń przez leki antyangiogenne prowadzi do zahamowania wzrostu guzów pierwotnych i przerzutów. W czasie długo...

Znaczenie białka macierzy jądrowej BLCA-4 w raku pęcherza moczowego

Rak pęcherza moczowego (RPM) występuje dosyć często i dotyka głównie osoby w starszym wieku. Zgodnie z informacją podaną przez Krajowy Rejestr Nowotworów w 2012 roku był to czwarty, pod względem zachorowania, nowotwór u...

Phospholipids and products of their hydrolysis as dietary preventive factors for civilization diseases

The results of numerous epidemiological studies indicate that phospholipids play an important role in the prevention of chronic diseases faced by contemporary society. Firstly, these compounds are responsible for the pro...

Beta-blockers and statins in the context of asthma

Asthma is a disease with a complex pathogenesis and differentiated clinical picture with airway inflammation in its background. Many cells and cell-released substances are engaged in the course of the disease. The basic...

Diversity of extended-spectrum beta-lactamase-producing Escherichia coli rods

Introduction: The aim of the study was to evaluate genetic relatedness and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing E. coli strains isolated from patients hospitalized in the University...

Download PDF file
  • EP ID EP66340
  • DOI -
  • Views 156
  • Downloads 0

How To Cite

Dariusz Moczulski, Iwona Majak (2009). An Overview of β-Oxidation Disorders. Advances in Hygiene and Experimental Medicine, 63(), 266-277. https://europub.co.uk/articles/-A-66340